Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Microb Genom ; 7(12)2021 12.
Artigo em Inglês | MEDLINE | ID: mdl-34898424

RESUMO

This study provides an update on invasive Haemophilus influenzae disease in Bellvitge University Hospital (2014-2019), reporting its evolution from a previous period (2008-2013) and analysing the non-typeable H. influenzae (NTHi) population structure using a clade-related classification. Clinical data, antimicrobial susceptibility and serotyping were studied and compared with those of the previous period. Population structure was assessed by multilocus sequence typing (MLST), SNP-based phylogenetic analysis and clade-related classification. The incidence of invasive H. influenzae disease remained constant between the two periods (average 2.07 cases per 100 000 population), while the 30 day mortality rate decreased (20.7-14.7 %, respectively). Immunosuppressive therapy (40 %) and malignancy (36 %) were the most frequent comorbidities. Ampicillin and fluoroquinolone resistance rates had increased between the two periods (10-17.6 % and 0-4.4 %, respectively). NTHi was the main cause of invasive disease in both periods (84.3 and 85.3 %), followed by serotype f (12.9 and 8.8 %). NTHi displayed high genetic diversity. However, two clusters of 13 (n=20) and 5 sequence types (STs) (n=10) associated with clade V included NTHi strains of the most prevalent STs (ST3 and ST103), many of which showed increased frequency over time. Moreover, ST103 and ST160 from clade V were associated with ß-lactam resistance. Invasive H. influenzae disease is uncommon, but can be severe, especially in the elderly with comorbidities. NTHi remains the main cause of invasive disease, with ST103 and ST160 (clade V) responsible for increasing ß-lactam resistance over time.


Assuntos
Farmacorresistência Bacteriana , Fluoroquinolonas/farmacologia , Infecções por Haemophilus/epidemiologia , Haemophilus influenzae/classificação , Tipagem de Sequências Multilocus/métodos , Polimorfismo de Nucleotídeo Único , Adulto , Idoso , Idoso de 80 Anos ou mais , Resistência a Ampicilina , Monitoramento Epidemiológico , Feminino , Infecções por Haemophilus/mortalidade , Haemophilus influenzae/genética , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Mortalidade , Filogenia , Espanha/epidemiologia , Sequenciamento Completo do Genoma , Adulto Jovem
2.
Int J Infect Dis ; 90: 161-166, 2020 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-31693939

RESUMO

OBJECTIVE: To analyse all cases of Nocardia pneumonia occurring between 2010 and 2016 in five Spanish hospitals. METHODS: This was a retrospective observational analysis of clinical and microbiological data collected from 55 cases of Nocardia pneumonia. RESULTS: There were one to 20 cases per hospital and six to nine cases per year. Chronic obstructive pulmonary disease, bronchiectasis, and asthma were the main predisposing underlying respiratory conditions. Thirty-four patients were receiving systemic and/or inhaled corticosteroids prior to infection, eight had neoplasia, and six had haematological malignancies. Clinical and radiological findings were common to pneumonia of other infectious aetiologies, except for the frequent presence of nodules and cavitation. Overall, the 1-year mortality was high (38.2%), and mortality was directly related to the pulmonary disease in 15 patients (27.3%). The most frequently identified species were N. cyriacigeorgica (n=21), N. abscessus (n=8), and N. farcinica (n=5). All Nocardia isolates were susceptible to linezolid and all but two were susceptible to amikacin and trimethoprim-sulfamethoxazole. CONCLUSIONS: Nocardia pneumonia-associated mortality remains high, probably because of the debilitated status of patients in whom this pathogen is able to cause pulmonary infection.


Assuntos
Nocardiose/microbiologia , Nocardia/isolamento & purificação , Pneumonia Bacteriana/microbiologia , Adulto , Idoso , Idoso de 80 Anos ou mais , Amicacina/farmacologia , Antibacterianos/farmacologia , Feminino , Humanos , Linezolida/farmacologia , Masculino , Pessoa de Meia-Idade , Nocardia/classificação , Nocardia/efeitos dos fármacos , Nocardia/genética , Nocardiose/epidemiologia , Nocardiose/imunologia , Pneumonia Bacteriana/epidemiologia , Pneumonia Bacteriana/imunologia , Estudos Retrospectivos , Espanha/epidemiologia , Combinação Trimetoprima e Sulfametoxazol , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA